Related Experiment Video
Updated: Mar 6, 2026
07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
1.3K
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approach
Andrew Loblaw1, Jack Barkin, Roger Buckley
1Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
The Canadian Journal of Urology
|March 7, 2017
Summary
A prostate cancer partnership formed by urologists and radiation oncologists created a patient guide. This consensus-driven approach aims to improve decision-making for localized prostate cancer patients.
Area of Science:
- Oncology
- Urology
- Radiation Oncology
Background:
- Standard treatments exist for localized prostate cancer.
- Multidisciplinary consultation is a quality objective for patient decision-making in Ontario.
- A prostate cancer community partnership consensus (PCPC) panel was formed to enhance collaboration and patient information.
Framework:
- The PCPC panel involved 40 prostate cancer specialists from six centers.
- Five iterative meetings defined partnership goals, topics, and questions.
- Formal consensus required >= 75% agreement via secret ballots.
Implementation:
- Forty-one questions addressing 30 issues were identified from literature and expert experience.
- Issues were cross-tabbed against five management options: active surveillance, radical prostatectomy, brachytherapy (low and high dose rate), and external beam radiation.
- Eighty-six issues were subjected to formal consensus, achieving agreement after three rounds of voting.
Implications:
- A consensus-based partnership between urology and radiation oncology is feasible.
- The partnership successfully developed a patient information guide.
- This guide has the potential to improve shared decision-making for newly diagnosed prostate cancer patients.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:27Peripheral Artery Disease III: Interprofessional Care
465
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465
01:28Acute Coronary Syndrome IV: Interprofessional Care
358
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
01:27Coronary Artery Disease V: Interprofessional Care
354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354